New Global shortage of Thyrogen through mid-November
New Global shortage of Thyrogen® through mid-November Genzyme Corporation (Cambridge, MA), currently under a consent decree with the U.S. Food and Drug Administration (FDA) regarding manufacturing issues of several products including Thyrogen®, is experiencing a new delay in its product release. This delay will affect the supply of Thyrogen® both in the US and globally such that it is unlikely that Thyrogen® will be available for use starting immediately. Healthcare providers and patients should therefore plan accordingly. The duration of the shortage is uncertain; however, the current best estimate is that it will last through mid-November. It may be advisable to not schedule use of Thyrogen® until product is confirmed to be available through your normal method of obtaining Thyrogen®. Additional information will be provided as it becomes available.
The American Thyroid Association (ATA) is the lead organization in promoting thyroid health and understanding thyroid biology. The ATA values scientific inquiry, clinical excellence, public service, education, collaboration, and collegiality.
A non-profit medical society founded in 1923, the ATA fulfills its mission through supporting excellence and innovation in research, clinical care, education, and public health. ATA members are physicians and scientists who work to enhance the understanding of thyroid physiology and pathophysiology, improve the diagnosis and treatment of thyroid diseases, and promote the education of physicians, patients, and the public about thyroid disorders.